Chiron Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,496
| Closed | -$5.9M | – | 129 |
|
|
2023
Q4 | $5.9M | Buy |
14,496
+13,841
| +2,113% | +$5.63M | 2.25% | 22 |
|
|
2023
Q3 | $228K | Sell |
655
-21,714
| -97% | -$7.55M | 0.1% | 48 |
|
|
2023
Q2 | $7.87M | Buy |
22,369
+12,859
| +135% | +$4.53M | 2.21% | 21 |
|
|
2023
Q1 | $3M | Buy |
9,510
+9,392
| +7,959% | +$2.96M | 0.54% | 36 |
|
|
2022
Q4 | $34.1K | Sell |
118
-69,156
| -100% | -$20M | 0.01% | 126 |
|
|
2022
Q3 | $20.1M | Sell |
69,274
-3,972
| -5% | -$1.15M | 4.04% | 7 |
|
|
2022
Q2 | $20.6M | Sell |
73,246
-13,875
| -16% | -$3.91M | 3.46% | 9 |
|
|
2022
Q1 | $22.7M | Buy |
+87,121
| New | +$22.7M | 2.61% | 17 |
|
|
2020
Q4 | – | Sell |
-33,274
| Closed | -$9.06M | – | 118 |
|
|
2020
Q3 | $9.06M | Buy |
33,274
+16,603
| +100% | +$4.52M | 1.68% | 33 |
|
|
2020
Q2 | $4.84M | Buy |
+16,671
| New | +$4.84M | 1.04% | 37 |
|
|
2019
Q2 | – | Sell |
-136,907
| Closed | -$25.2M | – | 59 |
|
|
2019
Q1 | $25.2M | Buy |
+136,907
| New | +$25.2M | 4.56% | 11 |
|